Browse studies
Find your next paid study
15 recruiting studies matching your filters
Phase 2
A Phase II Trial Evaluating 18F-Fluciclovine PET/CT in Multiple Myeloma
Background: Multiple myeloma (MM) is an incurable cancer of certain blood cells. MM often returns after treatment, and most people survive only 5 to 8 years a…
Multiple MyelomaNewly Diagnosed Multiple Myeloma (NDMM)Relapsed and/or Refractory Multiple Myeloma (RRMM)
National Cancer Institute (NCI)NCT06103838
Phase 1
Delivery of D2C7-IT and 2141-V11 Combination Immunotherapy in Residual Disease for Adult Patients With Newly Diagnosed MGMT Unmethylated Glioblastoma and Perilymphatic Subcutaneous Injections of 2141-V11
The purpose of this research study is to determine the safety and efficacy of administering a single intracerebral (within the brain) dose of investigational c…
Newly Diagnosed MGMT Unmethylated Glioblastoma
Darell BignerNCT05734560
Phase 1
A Phase 1 Study of Bispecific T Cell Engager (BRiTE) in Patients With Newly Diagnosed or Recurrent Glioblastoma
This Phase 1 study will assess the safety of a novel brain Bispecific T cell engager (BRiTE) in patients with newly diagnosed or recurrent World Health Organiz…
Newly Diagnosed GlioblastomaRecurrent Glioblastoma
Mustafa Khasraw, MBChB, MD, FRCP, FRACPNCT04903795